Structures by: Shundrina I. K.
Total: 17
4,10-di-tert-butyl-bis([1,2,3]dithiazolo)[5,4-a:5',4'-h]phenazine
C20H20N4S4
Chemical communications (Cambridge, England) (2020) 56, 5 727-730
a=13.634(3)Å b=23.059(5)Å c=6.8383(14)Å
α=90° β=90° γ=90°
C10H10N2S4,2(Cl4Ga),C4H10O
C10H10N2S4,2(Cl4Ga),C4H10O
Chemical communications (Cambridge, England) (2020) 56, 5 727-730
a=12.8899(3)Å b=21.9751(6)Å c=10.8024(3)Å
α=90° β=98.6730(10)° γ=90°
4,10-di-tert-butyl-bis([1,2,3]dithiazolo)[5,4-a:5',4'-h]phenazinediium bis(trifluoromethanesulfonate), solvate with acetonitrile
C10H10N2S2,CF3O3S,C2H3N
Chemical communications (Cambridge, England) (2020) 56, 5 727-730
a=7.7987(4)Å b=11.1508(6)Å c=11.7044(7)Å
α=68.737(2)° β=82.028(2)° γ=70.790(2)°
4,10-di-tert-butyl-bis([1,2,3]dithiazolo)[5,4-a:5',4'-h]phenazinediium bis(tetrachlorogallate), solvate with acetonitrile
C20H20N4S4,2(Cl4Ga),2(C2H3N)
Chemical communications (Cambridge, England) (2020) 56, 5 727-730
a=17.0008(15)Å b=12.4285(12)Å c=18.4315(18)Å
α=90° β=90° γ=90°
C20 H18 N4 S4, Cl4 Ga
C20H18N4S4,Cl4Ga
Chemical communications (Cambridge, England) (2020) 56, 5 727-730
a=15.6419(11)Å b=6.7683(5)Å c=25.762(3)Å
α=90° β=100.258(5)° γ=90°
4-tert-butylbenzo[1,2-d:3,4-d']bis([1,2,3]dithiazolium) bis(trifluoromethanesulfonate)
C10H10N2S4,2(CF3O3S)
Chemical communications (Cambridge, England) (2020) 56, 5 727-730
a=7.9057(7)Å b=11.8661(12)Å c=13.7217(14)Å
α=110.248(4)° β=104.718(4)° γ=97.976(4)°
4,7-di-tert-butylbis[1,2,3]dithiazolo[4'5':3,4;5',4':8,9]dibenzo [c,e][1?4?2,2,7]thiadiazepine
C20H20N4S5[solvent]
Chemical communications (Cambridge, England) (2020) 56, 5 727-730
a=26.008(5)Å b=7.0295(14)Å c=14.980(3)Å
α=90° β=120.32(3)° γ=90°
4,10-di-tert-butyl-bis([1,2,3]dithiazolo)[5,4-a:5',4'-h]phenazinediium bis(tetrachlorogallate), solvate with toluene
C20H20N4S4,2(C6),2(Cl4Ga)
Chemical communications (Cambridge, England) (2020) 56, 5 727-730
a=7.196(3)Å b=10.589(4)Å c=15.296(7)Å
α=100.190(14)° β=99.014(15)° γ=98.771(15)°
4,4'-2Me-1,4-bis(5-phenylfuran-2-yl)benzene
C28H22O2
CrystEngComm (2017) 19, 13 1809
a=11.0733(7)Å b=6.1594(3)Å c=15.8500(12)Å
α=90.00° β=110.183(2)° γ=90.00°
1,4-bis(5-phenylfuran-2-yl)benzene
C26H18O2
CrystEngComm (2017) 19, 13 1809
a=20.407(4)Å b=7.2998(14)Å c=6.2000(11)Å
α=90.00° β=97.773(6)° γ=90.00°
3,5,3',5'-4Me-1,4-bis(5-phenylfuran-2-yl)benzene
C30H26O2
CrystEngComm (2017) 19, 13 1809
a=13.2404(6)Å b=5.4901(2)Å c=15.3541(7)Å
α=90.00° β=90.015(2)° γ=90.00°
Bis(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6-methylpyrimidine)-iron(ii) bis(tetrafluoroborate)
C30H30FeN102,2(BF41)
Dalton transactions (Cambridge, England : 2003) (2015) 45, 1 107-120
a=12.8079(14)Å b=19.1932(19)Å c=27.373(3)Å
α=90° β=90° γ=90°
Bis(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6-methylpyrimidine)-iron(ii) bis(tetrafluoroborate) hemi(ethanol hydrate)
C30H30FeN102,2(BF41),0.41(C2H6O),0.4(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 45, 1 107-120
a=46.241(3)Å b=8.2140(5)Å c=18.5849(10)Å
α=90° β=93.444(4)° γ=90°
Bis(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6-methylpyrimidine)-iron(ii) bis(tetrafluoroborate) ethanol hydrate
C30H30FeN102,2(BF41),C2H6O,H2O
Dalton transactions (Cambridge, England : 2003) (2015) 45, 1 107-120
a=16.9811(4)Å b=11.3326(3)Å c=20.1037(6)Å
α=90° β=105.4330(10)° γ=90°
C14H8F3O
C14H8F3O
Acta Crystallographica Section B (2018) 74, 5
a=23.238(4)Å b=7.5293(11)Å c=6.2437(9)Å
α=90° β=92.830(6)° γ=90°
C14H8F3O
C14H8F3O
Acta Crystallographica Section B (2018) 74, 5
a=11.5050(10)Å b=6.2350(6)Å c=16.0118(16)Å
α=90° β=109.293(6)° γ=90°
C28H16F6O2
C28H16F6O2
Acta Crystallographica Section B (2018) 74, 5
a=20.5435(12)Å b=6.2569(3)Å c=35.797(2)Å
α=90° β=106.649(3)° γ=90°